I Stock 1018468972

We provide end-to-end (bio)analytical support to drug development from pre-clinical up to Phase IV studies.

PRA recognizes that the world of drug development is complex and dynamic. That's why we designed two fully harmonized laboratories to meet every challenge. We offer the highest quality services for pharmacokinetic, immunogenicity, biomarker, and CMC analysis, utilizing a wide range of platforms for small molecules, large molecules, and cell-based entities. PRA's Laboratories for Drug Development are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience necessary to successfully deliver the most complex of studies.

We believe that transparency is key when it comes to complex laboratory services. Our industry leading experts are always transparent throughout a study and immediately communicate what's going on. We deliver good news swiftly and bad news even faster, proactively solving any challenges and keeping your research on track.

The proximity of our labs to PRA's clinics enables us to analyze time-critical samples with short turnaround times. This allows us to advance your studies to the next phase faster than ever before.

Peter Ketelaar, Vice President, Laboratory Services

We’re enabling faster drug development decision-making.

Our GLP & GMP compliant facilities in the USA and the Netherlands adhere to the latest global regulatory guidelines and industry expectations. Our investments in technology and innovative service offerings are key components to developing optimal solutions for our clients.

Pushing research forward with specialized assay development

We offer specialized assay development in addition to non-proprietary assays, as well as validation to meet your specific needs, including PK, efficacy, and immunogenicity assays for both small and large molecules.

Learn more about PRA's bioanalytical laboratories

Start a conversation

You may also be interested in: